extremely significantP < 0.05
In our cohort, there were extremely significant differences in α-Gal A activity and Lyso-GL-3 between patients with Fabry disease and patients without Fabry disease of the same gender ( P < 0.05) in Tables 3 .
In our cohort, there were extremely significant differences in α-Gal A activity and Lyso-GL-3 between patients with Fabry disease and patients without Fabry disease of the same gender ( P < 0.05) in Tables 3 .